-
1
-
-
0036881059
-
Plasminogen activator inhibitor-1 levels and polymorphisms. Association with venous thromboembolism
-
Francis CW Plasminogen activator inhibitor-1 levels and polymorphisms. Association with venous thromboembolism. Arch Pathol Lab Med. 2002 ; 126: 1401-1404.
-
(2002)
Arch Pathol Lab Med.
, vol.126
, pp. 1401-1404
-
-
Francis, C.W.1
-
2
-
-
0035169759
-
Plasminogen activator inhibitor type-1: Basic mechanisms, regulation, and role for thromboembolic disease
-
Huber K. Plasminogen activator inhibitor type-1: basic mechanisms, regulation, and role for thromboembolic disease. J Thromb Thrombolysis. 2001 ; 11: 183-193.
-
(2001)
J Thromb Thrombolysis
, vol.11
, pp. 183-193
-
-
Huber, K.1
-
3
-
-
0031732774
-
4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep-vein thrombosis
-
Sartori MT, Wiman B., Vettore S., et al. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep-vein thrombosis. Thromb Haemost. 1998 ; 80: 956-960.
-
(1998)
Thromb Haemost
, vol.80
, pp. 956-960
-
-
Sartori, M.T.1
Wiman, B.2
Vettore, S.3
-
4
-
-
0021889294
-
Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: Low concentration of plasminogen activator increased concentration of plasminogen activator inhibitor
-
Nilsson IM, Ljungner H., Tengborn L. Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator increased concentration of plasminogen activator inhibitor. BMJ. 1985 ; 290: 1453-1456.
-
(1985)
BMJ
, vol.290
, pp. 1453-1456
-
-
Nilsson, I.M.1
Ljungner, H.2
Tengborn, L.3
-
5
-
-
0029880730
-
The significance of hypofibrinolysis for the risk of recurrence of venous thromboembolism
-
the Duration of Anticoagulation (DURAC) Trial Study Group.
-
Schulman S., Wiman B., the Duration of Anticoagulation (DURAC) Trial Study Group. The significance of hypofibrinolysis for the risk of recurrence of venous thromboembolism. Thromb Haemost. 1996 ; 75: 607-611.
-
(1996)
Thromb Haemost
, vol.75
, pp. 607-611
-
-
Schulman, S.1
Wiman, B.2
-
6
-
-
0031016432
-
Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men
-
Ridker PM, Hennekens CH, Lindpaintner K., et al. Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men. Circulation. 1997 ; 95: 59-63.
-
(1997)
Circulation
, vol.95
, pp. 59-63
-
-
Ridker, P.M.1
Hennekens, C.H.2
Lindpaintner, K.3
-
7
-
-
0031966645
-
The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: Relationship to plasma PAI-1 level in venous thromboembolism
-
Stegnar M., Uhrin P., Petrnel P., et al. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism. Thromb Haemost. 1998 ; 9: 975-979.
-
(1998)
Thromb Haemost
, vol.9
, pp. 975-979
-
-
Stegnar, M.1
Uhrin, P.2
Petrnel, P.3
-
8
-
-
0034209632
-
The role of the t-PA I/D and PAI-1 4G/5G polymorphisms in African-American adults with a diagnosis of myocardial infarction or venous thromboembolism
-
Hooper WC, Lally C., Austin H., et al. The role of the t-PA I/D and PAI-1 4G/5G polymorphisms in African-American adults with a diagnosis of myocardial infarction or venous thromboembolism. Thromb Res. 2000 ; 99: 223-230.
-
(2000)
Thromb Res
, vol.99
, pp. 223-230
-
-
Hooper, W.C.1
Lally, C.2
Austin, H.3
-
9
-
-
0242333862
-
Factor V leiden, prothrombin 20210G-A, methylene tetrahydrofolate reductase 677C-T and plasminogen activator inhibitor 4G/5G polymorphism in women with pregnancy-related venous thromboembolism
-
Meglic L., Stegnar M., Milanez T., et al. Factor V leiden, prothrombin 20210G-A, methylene tetrahydrofolate reductase 677C-T and plasminogen activator inhibitor 4G/5G polymorphism in women with pregnancy-related venous thromboembolism. Eur J Obstet Gynecol Reprod Biol. 2003 ; 111: 157-163.
-
(2003)
Eur J Obstet Gynecol Reprod Biol
, vol.111
, pp. 157-163
-
-
Meglic, L.1
Stegnar, M.2
Milanez, T.3
-
10
-
-
0033967394
-
Effect of plasminogen activator inhibitor-1 4G/5G polymorphism in Turkish deep vein thrombotic patients with and without FV 1691 G-A
-
Akar N., Yilmaz E., Akar E., et al. Effect of plasminogen activator inhibitor-1 4G/5G polymorphism in Turkish deep vein thrombotic patients with and without FV 1691 G-A. Thromb Res. 2000 ; 97: 227-230.
-
(2000)
Thromb Res
, vol.97
, pp. 227-230
-
-
Akar, N.1
Yilmaz, E.2
Akar, E.3
-
11
-
-
0033621632
-
Effect of MTHFR 677 C-T, 1298 A-C and 1317 T-C on Factor V 1691 mutation in Turkish DVT patients
-
Akar N., Akar E., Akcay R., et al. Effect of MTHFR 677 C-T, 1298 A-C and 1317 T-C on Factor V 1691 mutation in Turkish DVT patients. Thromb Res. 2000 ; 97: 163-167.
-
(2000)
Thromb Res
, vol.97
, pp. 163-167
-
-
Akar, N.1
Akar, E.2
Akcay, R.3
-
12
-
-
17744410104
-
Prothrombin gene 20210 G-A mutation in the Turkish population
-
Akar N., Misirlioglu M., Akar E., et al. Prothrombin gene 20210 G-A mutation in the Turkish population. Am J Hematol. 1998 ; 58: 249.
-
(1998)
Am J Hematol
, vol.58
, pp. 249
-
-
Akar, N.1
Misirlioglu, M.2
Akar, E.3
-
13
-
-
0346903208
-
Allele 4G of gene PAI-1 associated with prothrombin mutation G20210A increases the risk for venous thrombosis
-
Barcellona D., Lara F., Cauli C., et al. Allele 4G of gene PAI-1 associated with prothrombin mutation G20210A increases the risk for venous thrombosis. Thromb Haemost. 2003 ; 90: 1061-1064.
-
(2003)
Thromb Haemost
, vol.90
, pp. 1061-1064
-
-
Barcellona, D.1
Lara, F.2
Cauli, C.3
-
14
-
-
0033871724
-
Influence of the -675 4G/5G dimorphism of the plasminogen activator inhibitor 1 promoter on thrombotic risk in patients with factor V leiden
-
Visanji JM, Seargent J., Tahri D., et al. Influence of the -675 4G/5G dimorphism of the plasminogen activator inhibitor 1 promoter on thrombotic risk in patients with factor V leiden. Br J Haematol. 2000 ; 110: 135-138.
-
(2000)
Br J Haematol
, vol.110
, pp. 135-138
-
-
Visanji, J.M.1
Seargent, J.2
Tahri, D.3
-
15
-
-
0031725369
-
Plasminogen activator inhibitor-1 4G/4G genotype is associated with cerebral sinus thrombosis in factor V leiden carriers
-
Junker R., Nabavi DG, Wolff E., et al. Plasminogen activator inhibitor-1 4G/4G genotype is associated with cerebral sinus thrombosis in factor V leiden carriers. Thromb Haemost. 1998 ; 80: 706-707.
-
(1998)
Thromb Haemost
, vol.80
, pp. 706-707
-
-
Junker, R.1
Nabavi, D.G.2
Wolff, E.3
-
16
-
-
2642692693
-
A common 4G allele in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene as a risk factor for pulmonary embolism and arterial thrombosis in hereditary protein S deficiency
-
Zöller B., Frutos PB, Dahlback B. A common 4G allele in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene as a risk factor for pulmonary embolism and arterial thrombosis in hereditary protein S deficiency. Thromb Haemost. 1998 ; 79: 802-807.
-
(1998)
Thromb Haemost
, vol.79
, pp. 802-807
-
-
Zöller, B.1
Frutos, P.B.2
Dahlback, B.3
-
17
-
-
0033785047
-
The 4G/5G polymorphism of the type 1 plasminogen activator inhibitor gene and thrombosis in patients with antiphospholipid syndrome
-
Tassies D., Espinosa G., Munoz-Rodriguez FJ, et al. The 4G/5G polymorphism of the type 1 plasminogen activator inhibitor gene and thrombosis in patients with antiphospholipid syndrome. Arthritis Rheum. 2000 ; 43: 2349-2358.
-
(2000)
Arthritis Rheum
, vol.43
, pp. 2349-2358
-
-
Tassies, D.1
Espinosa, G.2
Munoz-Rodriguez, F.J.3
-
19
-
-
0033739241
-
Deep vein thrombosis and pulmonary embolism: A single entity with different risk factors
-
Perrier A. Deep vein thrombosis and pulmonary embolism: a single entity with different risk factors. Chest. 2000 ; 118: 1234-1236.
-
(2000)
Chest
, vol.118
, pp. 1234-1236
-
-
Perrier, A.1
-
20
-
-
33847733692
-
Management of pulmonary thromboembolic diseases
-
Crapo JD, Glassroth J, Karlinsky J, King TE Jr, eds. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins;
-
Morris TA Management of pulmonary thromboembolic diseases. In: Crapo JD, Glassroth J, Karlinsky J, King TE Jr, eds. Baum's Textbook of Pulmonary Diseases. 7 th ed. Philadelphia, PA: Lippincott Williams & Wilkins ; 2004: 747-771.
-
(2004)
Baum's Textbook of Pulmonary Diseases
, pp. 747-771
-
-
Morris, T.A.1
|